I

Illumina

Develops sequencing platforms and consumables

Director Market Access - CMS Coverage & Reimbursement Policy

Business & StrategyUpdated on Nov 11
Full-timeWashington, DC, USA

About the Job

Requirements

  • A bachelor's degree is required; an advanced degree is preferred, such as an MPH, MHA, PharmD, PhD, JD, MBA, or equivalent.
  • At least 10 years of experience in Medicare reimbursement, federal health policy, or market access.
  • Demonstrated experience leading Medicare coverage and reimbursement strategies for genomic sequencing, genetic testing, molecular diagnostics, precision medicine, or other advanced diagnostic technologies.
  • More than 5 years of direct experience working with CMS, Medicare Administrative Contractors, MolDx, or other Medicare reimbursement and policy organizations; experience at CMS is ideal.
  • Demonstrated success influencing Medicare coverage, coding, pricing, or reimbursement policy.
  • Deep knowledge of NCDs, LCDs, CLFS, CPT and PLA coding, gapfill and crosswalk pricing, and Medicare payment policy.
  • Excellent policy analysis, stakeholder engagement, and executive communication skills.

Responsibilities

  • Lead Medicare market access strategies for genomic sequencing and genetic testing.
  • Develop strategies for NCDs, LCDs, MolDx, MAC engagement, CLFS pricing, CPT/PLA coding, and reimbursement.
  • Monitor CMS rulemaking and federal reimbursement policy developments.
  • Partner with Government Affairs on federal advocacy and policy initiatives.
  • Collaborate with Medical Affairs and HEOR to develop evidence supporting Medicare coverage.
  • Represent the company with CMS, Medicare contractors, and industry organizations.
  • Travel approximately 25–35%.

About the Company

Illumina

Develops sequencing platforms and consumables

Illumina develops and sells integrated sequencing systems and the consumables needed to analyze genetic variation and biological function. Its instruments use sequencing-by-synthesis on flow-cell-based platforms, with specialized reagents and library preparation kits that are consumed per run. The company differentiates itself through a broad end-to-end ecosystem, a large installed base that drives repeat purchases, and strategic acquisitions that expand capabilities into multiomics and clinical applications. Its goal is to advance genomic analysis for research and clinical diagnostics to enable personalized medicine and early cancer detection.

Company size
5,001-10,000
Company stage
IPO
Headquarters
San Diego, CA
Founded
1998

Recently Posted Jobs

Explore more opportunities at Illumina

See more jobs